DSG Global Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DSG Global Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $3.83M | Jul 13, 2023 |
| FY2017 | Dec 31, 2017 | $1.10M | Apr 25, 2018 |
| FY2017 | Dec 31, 2016 | $1.17M | Apr 25, 2018 |
| FY2013 | Sep 30, 2013 | $0 | Jan 15, 2014 |
| FY2013 | Sep 30, 2012 | $0 | Jan 15, 2014 |
| FY2012 | Sep 30, 2011 | $0 | Jan 7, 2013 |
| FY2011 | Sep 30, 2010 | $0 | Apr 25, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $3.83M | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $2.09M | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $900.5K | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.40M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.28M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.10M | May 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.75M | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $982.1K | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $490.7K | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $451.1K | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.09M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $712.4K | May 28, 2019 |
| FY2017 | Dec 31, 2016 | $656.3K | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | $771.9K | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $1.54M | May 2, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($7.55M) | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | ($6.38M) | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | ($6.18M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($3.08M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($9.83M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($4.12M) | May 28, 2019 |
| FY2017 | Dec 31, 2016 | ($2.31M) | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | ($2.09M) | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | ($2.96M) | May 2, 2016 |
| FY2014 | Sep 30, 2014 | ($30.3K) | Feb 18, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($5.25M) | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | ($5.95M) | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | ($5.07M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($2.43M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($1.18M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($1.64M) | May 28, 2019 |
| FY2017 | Dec 31, 2016 | ($1.69M) | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | ($1.84M) | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | ($544.2K) | May 2, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $52.3K | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $388.0K | Jul 13, 2023 |
| FY2017 | Dec 31, 2016 | $58.1K | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | $41.1K | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $6.8K | May 2, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($3.62M) | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | ($5.61M) | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | ($1.40M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($848.8K) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($1.42M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($569.0K) | May 28, 2019 |
| FY2017 | Dec 31, 2016 | ($620.2K) | Apr 25, 2018 |
| FY2013 | Sep 30, 2013 | ($7.6K) | Jan 15, 2014 |
| FY2013 | Sep 30, 2012 | ($13.9K) | Jan 15, 2014 |
| FY2012 | Sep 30, 2011 | ($9.1K) | Jan 7, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $8.9K | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $26.5K | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $23.2K | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.4K | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.6K | May 15, 2020 |
| FY2017 | Dec 31, 2016 | $2.0K | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | $9.5K | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $30.0K | May 2, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.24M | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $2.61M | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $2.10M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $406.1K | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $352.7K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $90.7K | May 28, 2019 |
| FY2017 | Dec 31, 2016 | $290.8K | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | $787.3K | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $1.40M | May 2, 2016 |
| FY2014 | Sep 30, 2014 | $2.3K | Feb 18, 2015 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $9.16M | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $4.27M | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $2.91M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $8.70M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $7.02M | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $8.55M | May 28, 2019 |
| FY2014 | Sep 30, 2014 | $62.1K | Feb 18, 2015 |
| FY2014 | Sep 30, 2013 | $39.4K | Feb 18, 2015 |
| FY2013 | Sep 30, 2012 | $27.3K | Jan 15, 2014 |
| FY2012 | Sep 30, 2011 | $13.5K | Jan 7, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | ($13.74M) | May 28, 2019 |
| FY2017 | Dec 31, 2016 | ($9.70M) | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | ($7.50M) | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | ($403.4K) | May 2, 2016 |
| FY2014 | Sep 30, 2014 | ($59.7K) | Feb 18, 2015 |
| FY2014 | Sep 30, 2013 | ($29.4K) | Feb 18, 2015 |
| FY2014 | Sep 30, 2012 | ($16.6K) | Feb 18, 2015 |
| FY2014 | Sep 30, 2011 | ($3.9K) | Feb 18, 2015 |
| FY2014 | Sep 30, 2010 | $7.4K | Feb 18, 2015 |
| FY2014 | Sep 30, 2009 | $19.5K | Feb 18, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($65.24M) | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | ($57.69M) | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | ($51.31M) | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | ($45.13M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($42.05M) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | ($32.23M) | May 28, 2019 |
| FY2017 | Dec 31, 2016 | ($27.01M) | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | ($24.71M) | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | ($22.63M) | May 2, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $53.8K | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | $275.4K | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | $1.37M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | $25.5K | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $5.1K | May 15, 2020 |
| FY2018 | Dec 31, 2017 | $5.5K | May 28, 2019 |
| FY2016 | Dec 31, 2014 | $91.8K | Apr 28, 2017 |
| FY2014 | Sep 30, 2014 | $2.3K | Feb 18, 2015 |
| FY2014 | Sep 30, 2013 | $476 | Feb 18, 2015 |
| FY2014 | Sep 30, 2012 | $1.2K | Feb 18, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 0 | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | (3) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | (28) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | (372) | May 28, 2019 |
| FY2016 | Dec 31, 2016 | 0 | Apr 28, 2017 |
| FY2016 | Dec 31, 2015 | 0 | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | 0 | May 2, 2016 |
| FY2014 | Sep 30, 2014 | 0 | Feb 18, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 0 | Apr 1, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | (3) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | (28) | May 15, 2020 |
| FY2018 | Dec 31, 2017 | (372) | May 28, 2019 |
| FY2016 | Dec 31, 2016 | 0 | Apr 28, 2017 |
| FY2016 | Dec 31, 2015 | 0 | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | 0 | May 2, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 145.43M | Jul 13, 2023 |
| FY2022 | Dec 31, 2021 | 128.35M | Jul 13, 2023 |
| FY2021 | Dec 31, 2020 | 95.77M | Apr 1, 2022 |
| FY2020 | Dec 31, 2019 | 1.15M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | 634,471 | May 15, 2020 |
| FY2018 | Dec 31, 2017 | 25,485 | May 28, 2019 |
| FY2017 | Dec 31, 2016 | 30.29M | Apr 25, 2018 |
| FY2016 | Dec 31, 2015 | 30.29M | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | 20.11M | May 2, 2016 |
| FY2014 | Sep 30, 2014 | 30.00M | Feb 18, 2015 |